Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

по Doi, Toshihiko, Ohtsu, Atsushi, Fuse, Nozomu, Yoshino, Takayuki, Tahara, Makoto, Shibayama, Kazuhiro, Takubo, Takatoshi, Weinreich, David M.
Опубликовано 2012

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer

по Doi, Toshihiko, Yoshino, Takayuki, Fuse, Nozomu, Boku, Narikazu, Yamazaki, Kentaro, Koizumi, Wasaburo, Shimada, Ken, Takinishi, Yasutaka, Ohtsu, Atsushi
Опубликовано в: Invest New Drugs (2015)

A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors

по Doi, Toshihiko, Fuse, Nozomu, Yoshino, Takayuki, Kojima, Takashi, Bando, Hideaki, Miyamoto, Hideaki, Kaneko, Masato, Osada, Motonobu, Ohtsu, Atsushi
Опубликовано в: Cancer Chemother Pharmacol (2016)

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

по Doi, Toshihiko, Onozawa, Yusuke, Fuse, Nozomu, Yoshino, Takayuki, Yamazaki, Kentaro, Watanabe, Junichiro, Akimov, Mikhail, Robson, Matthew, Boku, Narikazu, Ohtsu, Atsushi
Опубликовано 2014

Phase 1 pharmacokinetic study of MK-0646 (dalotuzumab), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in combination with cetuximab and irinotecan in Japanese...

по Doi, Toshihiko, Muro, Kei, Yoshino, Takayuki, Fuse, Nozomu, Ura, Takashi, Takahari, Daisuke, Feng, Hwa-ping, Shimamoto, Takashi, Noguchi, Kazuo, Ohtsu, Atsushi
Опубликовано 2013

Phase 1 pharmacokinetic study of the oral pan-AKT inhibitor MK-2206 in Japanese patients with advanced solid tumors

по Doi, Toshihiko, Tamura, Kenji, Tanabe, Yuko, Yonemori, Kan, Yoshino, Takayuki, Fuse, Nozomu, Kodaira, Makoto, Bando, Hideaki, Noguchi, Kazuo, Shimamoto, Takashi, Ohtsu, Atsushi
Опубликовано в: Cancer Chemother Pharmacol (2015)

Effect of food on the pharmacokinetics of TAS‐102 and its efficacy and safety in patients with advanced solid tumors

по Yoshino, Takayuki, Kojima, Takashi, Bando, Hideaki, Yamazaki, Tomoko, Naito, Yoichi, Mukai, Hirofumi, Fuse, Nozomu, Goto, Koichi, Ito, Yuko, Doi, Toshihiko, Ohtsu, Atsushi
Опубликовано в: Cancer Sci (2016)

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tum...

по Murakami, Haruyasu, Doi, Toshihiko, Yamamoto, Nobuyuki, Watanabe, Junichiro, Boku, Narikazu, Fuse, Nozomu, Yoshino, Takayuki, Ohtsu, Atsushi, Otani, Satoru, Shibayama, Kazuhiro, Takubo, Takatoshi, Loh, Elwyn
Опубликовано 2012

A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer

по Kawazoe, Akihito, Shitara, Kohei, Fukuoka, Shota, Kuboki, Yasutoshi, Bando, Hideaki, Okamoto, Wataru, Kojima, Takashi, Fuse, Nozomu, Yamanaka, Takeharu, Doi, Toshihiko, Ohtsu, Atsushi, Yoshino, Takayuki
Опубликовано в: BMC Cancer (2015)

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

по Tahara, Makoto, Fuse, Nozomu, Mizusawa, Junki, Sato, Akihiro, Nihei, Keiji, Kanato, Keisuke, Kato, Ken, Yamazaki, Kentaro, Muro, Kei, Takaishi, Hiromasa, Boku, Narikazu, Ohtsu, Atsushi
Опубликовано в: Cancer Sci (2015)

Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study

по Fuse, Nozomu, Bando, Hideaki, Chin, Keisho, Ito, Seiji, Yoshikawa, Takaki, Tsuburaya, Akira, Terashima, Masanori, Kawashima, Yoshiyuki, Fukunaga, Tetsu, Gotoh, Masahiro, Emi, Yasunori, Yoshida, Kazuhiro, Oki, Eiji, Takahashi, Seiji, Kuriki, Hiroshi, Sato, Kumi, Sasako, Mitsuru
Опубликовано в: Gastric Cancer (2016)

TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esoph...

по Bando, Hideaki, Kotani, Daisuke, Tsushima, Takahiro, Hara, Hiroki, Kadowaki, Shigenori, Kato, Ken, Chin, Keisho, Yamaguchi, Kensei, Kageyama, Shun-ichiro, Hojo, Hidehiro, Nakamura, Masaki, Tachibana, Hidenobu, Wakabayashi, Masashi, Fukutani, Miki, Togashi, Yosuke, Fuse, Nozomu, Nishikawa, Hiroyoshi, Kojima, Takashi
Опубликовано в: BMC Cancer (2020)

Guidelines for clinical evaluation of anti‐cancer drugs

по Minami, Hironobu, Kiyota, Naomi, Kimbara, Shiro, Ando, Yuichi, Shimokata, Tomoya, Ohtsu, Atsushi, Fuse, Nozomu, Kuboki, Yasutoshi, Shimizu, Toshio, Yamamoto, Noboru, Nishio, Kazuto, Kawakami, Yutaka, Nihira, Shin‐ichi, Sase, Kazuhiro, Nonaka, Takahiro, Takahashi, Hideaki, Komori, Yukiko, Kiyohara, Koshin
Опубликовано в: Cancer Sci (2021)

Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer

по Yamada, Yasuhide, Koizumi, Wasaburo, Nishikawa, Kazuhiro, Gotoh, Masahiro, Fuse, Nozomu, Sugimoto, Naotoshi, Nishina, Tomohiro, Amagai, Kenji, Chin, Keisho, Niwa, Yasumasa, Tsuji, Akihito, Imamura, Hiroshi, Tsuda, Masahiro, Yasui, Hirofumi, Fujii, Hirofumi, Yamaguchi, Kensei, Yasui, Hisateru, Hironaka, Shuichi, Shimada, Ken, Hyodo, Ichinosuke
Опубликовано в: Cancer Sci (2019)

Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with BRAF V600E mutant metastatic colorectal cancer

по Masuishi, Toshiki, Taniguchi, Hiroya, Kotani, Daisuke, Bando, Hideaki, Komatsu, Yoshito, Shinozaki, Eiji, Nakajima, Takako Eguchi, Satoh, Taroh, Nishina, Tomohiro, Esaki, Taito, Wakabayashi, Masashi, Nomura, Shogo, Takahashi, Koji, Ono, Hiromi, Hirano, Nami, Fujishiro, Noriko, Fuse, Nozomu, Sato, Akihiro, Ohtsu, Atsushi, Yoshino, Takayuki
Опубликовано в: ESMO Open (2019)

BIG BANG study (EPOC1703): multicentre, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy with binimetinib, encorafenib and cetuximab in pa...

по Kotani, Daisuke, Bando, Hideaki, Taniguchi, Hiroya, Masuishi, Toshiki, Komatsu, Yoshito, Yamaguchi, Kensei, Nakajima, Takako, Satoh, Taroh, Nishina, Tomohiro, Esaki, Taito, Nomura, Shogo, Takahashi, Koji, Iida, Shinobu, Matsuda, Seiko, Motonaga, Shinya, Fuse, Nozomu, Sato, Akihiro, Fujii, Satoshi, Ohtsu, Atsushi, Ebi, Hiromichi, Yoshino, Takayuki
Опубликовано в: ESMO Open (2020)

Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis

по Paoletti, Xavier, Oba, Koji, Bang, Yung-Jue, Bleiberg, Harry, Boku, Narikazu, Bouché, Olivier, Catalano, Paul, Fuse, Nozomu, Michiels, Stefan, Moehler, Markus, Morita, Satoshi, Ohashi, Yasuo, Ohtsu, Atsushi, Roth, Arnaud, Rougier, Philippe, Sakamoto, Junichi, Sargent, Daniel, Sasako, Mitsuru, Shitara, Kohei, Thuss-Patience, Peter, Van Cutsem, Eric, Burzykowski, Tomasz, Buyse, Marc
Опубликовано в: J Natl Cancer Inst (2013)

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer

по Satoh, Taroh, Lee, Kyung Hee, Rha, Sun Young, Sasaki, Yasutsuna, Park, Se Hoon, Komatsu, Yoshito, Yasui, Hirofumi, Kim, Tae-You, Yamaguchi, Kensei, Fuse, Nozomu, Yamada, Yasuhide, Ura, Takashi, Kim, Si-Young, Munakata, Masaki, Saitoh, Soh, Nishio, Kazuto, Morita, Satoshi, Yamamoto, Eriko, Zhang, Qingwei, Kim, Jung-mi, Kim, Yeul Hong, Sakata, Yuh
Опубликовано в: Gastric Cancer (2014)